1. Home
  2. ADSK vs ZTS Comparison

ADSK vs ZTS Comparison

Compare ADSK & ZTS Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

Logo Autodesk Inc.

ADSK

Autodesk Inc.

HOLD

Current Price

$223.20

Market Cap

56.9B

Sector

Technology

ML Signal

HOLD

Logo Zoetis Inc.

ZTS

Zoetis Inc.

HOLD

Current Price

$125.51

Market Cap

54.8B

Sector

Health Care

ML Signal

HOLD

Company Overview

Basic Information
Metric
ADSK
ZTS
Founded
1982
1952
Country
United States
United States
Employees
N/A
N/A
Industry
Computer Software: Prepackaged Software
Biotechnology: Pharmaceutical Preparations
Sector
Technology
Health Care
Exchange
Nasdaq
Nasdaq
Market Cap
56.9B
54.8B
IPO Year
N/A
2013

Fundamental Metrics

Financial Performance
Metric
ADSK
ZTS
Price
$223.20
$125.51
Analyst Decision
Strong Buy
Buy
Analyst Count
26
11
Target Price
$365.77
$166.60
AVG Volume (30 Days)
2.3M
4.6M
Earning Date
02-26-2026
02-12-2026
Dividend Yield
N/A
1.65%
EPS Growth
2.41
11.64
EPS
5.15
5.94
Revenue
$6,888,000,000.00
$9,397,000,000.00
Revenue This Year
$19.18
$3.04
Revenue Next Year
$11.19
$4.99
P/E Ratio
$45.15
$21.67
Revenue Growth
15.55
2.68
52 Week Low
$229.52
$115.25
52 Week High
$329.09
$177.00

Technical Indicators

Market Signals
Indicator
ADSK
ZTS
Relative Strength Index (RSI) 24.73 53.66
Support Level $236.43 $126.34
Resistance Level $247.12 $129.95
Average True Range (ATR) 8.84 3.67
MACD -1.72 0.39
Stochastic Oscillator 12.03 58.01

Price Performance

Historical Comparison
ADSK
ZTS

About ADSK Autodesk Inc.

Founded in 1982, Autodesk is a multinational software company best known for pioneering computer-aided design, or CAD, with its AutoCAD product. Nowadays, Autodesk provides design software for a variety of verticals, including architecture & construction, manufacturing, and media & entertainment. Autodesk products have been used in some of the world's most iconic landmarks, like Burj Khalifa, and well-known movie titles like Avatar.

About ZTS Zoetis Inc.

Zoetis sells anti-infectives, vaccines, parasiticides, diagnostics, and other health products for animals. The firm earns roughly 35% of total revenue from production animals (cattle, pigs, poultry, and so on) and nearly 65% from companion animal (dogs, horses, cats) products. Its USA business is skewed even more heavily toward companion animals, while its international business is slightly skewed toward production animals. The firm has the largest market share in the industry and was previously Pfizer's animal health unit.

Share on Social Networks: